Trial NCT05498792

View at ClinicalTrials.gov 
Org. Study IDs: MEL-212
Secondary IDs: 22-1028

Last trial update was posted on 2024-03-20

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Melanoma

Other Conditions

Locally Advanced or Metastatic Melanoma

Stopping Reasons

Paused for safety cohort review

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID